Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | SLC5A2 | P31639 | 6/20 | 0.41 |
| ▸ | SLC5A1 | P13866 | 5/20 | 0.41 |
| ▸ | HTR2A | P28223 | 4/20 | 0.40 |
| ▸ | HTR1D | P28221 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27085168 | 0.96 | HTR2A (0.46) | HTR6BCHEACHESLC5A2SLC5A1 | |
| SCHEMBL27085103 | 0.93 | HTR6 (0.45) | HTR6BCHEACHESLC5A2SLC5A1 | |
| SCHEMBL27085003 | 0.89 | SLC5A2 (0.53) | HTR6SLC5A2SLC5A1ATM | |
| SCHEMBL27085000 | 0.89 | HTR6 (0.47) | HTR6BCHEACHESLC5A2SLC5A1 | |
| SCHEMBL27085236 | 0.89 | HTR6 (0.58) | HTR6SLC5A2SLC5A1HTR2AATM | |
| SCHEMBL27084930 | 0.88 | HTR6 (0.45) | HTR6BCHEACHESLC5A2SLC5A1 | |
| SCHEMBL27085218 | 0.87 | HTR6 (0.41) | HTR6BCHEACHESLC5A2SLC5A1 | |
| SCHEMBL27085174 | 0.87 | HTR6 (0.43) | HTR6BCHEACHESLC5A2SLC5A1 | |
| SCHEMBL27084990 | 0.86 | HTR6 (0.44) | HTR6BCHEACHESLC5A2SLC5A1 | |
| SCHEMBL27084830 | 0.86 | SLC5A2 (0.51) | SLC5A2SLC5A1HTR2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240043382-A1 | MODIFIED INDOLE ALKALOIDS FOR THERAPEUTIC USES | COMPASS PATHFINDER LIMITED (GB) | 2024-02-08 | — | — | US | disclosed |
| CN-117120415-A | Modified indole alkaloids for therapeutic use | 指南针探路者有限公司 | 2023-11-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240043382-A1 | MODIFIED INDOLE ALKALOIDS FOR THERAPEUTIC USES | INMT, AANAT, HNMT | HTR6 57/4885BCHE 7/4885ACHE 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.